Sign Up to like & get
recommendations!
1
Published in 2022 at "Advanced Materials"
DOI: 10.1002/adma.202209379
Abstract: Immune checkpoint blockade (ICB) therapy shows excellent efficacy against malignancies; however, insufficient tumor immunogenicity and the immunosuppressive tumor microenvironment (TME) are considered as the two major stumbling blocks to a broad ICB response. Here, a…
read more here.
Keywords:
antitumor immune;
pyroptosis;
combined oncolytic;
dual responsive ... See more keywords